20 mg atorvastatin nightly for 3 months	placebo	mean of HCV-RNA numbers in 12 weeks of therapy	1163	1362	We didn't find any significant differences in the mean of HCV-RNA numbers between statin and placebo groups in 12th week of treatment, in the end of treatment and 6 months after treatment (P > 0.05).
20 mg atorvastatin nightly for 3 months	placebo	mean of HCV-RNA numbers 6 months after treatment 	1163	1362	We didn't find any significant differences in the mean of HCV-RNA numbers between statin and placebo groups in 12th week of treatment, in the end of treatment and 6 months after treatment (P > 0.05).
20 mg atorvastatin nightly for 3 months	placebo	mean of HCV-RNA numbers at the end of treatment 	9585	9766	we didn't find any significant differences in the mean of HCV-RNA numbers in statin and placebo groups in 12th week of Statins therapy (P > 0.05), at the end of treatment (P > 0.05)
20 mg atorvastatin nightly for 3 months	placebo	mean of HCV-RNA numbers in 12 weeks of therapy	9585	9731	we didn't find any significant differences in the mean of HCV-RNA numbers in statin and placebo groups in 12th week of Statins therapy (P > 0.05),
20 mg atorvastatin nightly for 3 months	placebo	mean of HCV-RNA numbers 6 months after treatment 	9585	9806	we didn't find any significant differences in the mean of HCV-RNA numbers in statin and placebo groups in 12th week of Statins therapy (P > 0.05), at the end of treatment (P > 0.05) and 6 months after treatment (P > 0.05)
20 mg atorvastatin nightly for 3 months	placebo	mean of HCV-RNA numbers at the end of treatment 	-1	-1	We didnï¿½??t find any significant differences in the mean of HCV-RNA numbers between statin and placebo groups in 12th week of treatment, in the end of treatment and 6 months after treatment (P > 0.05).
